6 May 2024 in Rheumatology
This study aimed to evaluate the activity of the glymphatic system in SLE using a diffusion-based method termed ‘Diffusion Tensor Image Analysis aLong the Perivascular Space (DTI-ALPS)’, and to examine its correlations with morphological changes in the brain. In this cross-sectional study, 45 female patients with SLE and 30 healthy controls (HCs) were included. Voxel-based and surface-based morphometric analyses were performed to examine T1-weighted images, and diffusion tensor images were acquired to determine diffusivity along the x-, y- and z-axes in the plane of the lateral ventricle body. The DTI-ALPS index (ALPS index) was calculated for each patient. The differences in values between patients with SLE and the HC group were compared using the independent samples t test or the Mann–Whitney U test. To determine correlations between the ALPS index and brain morphological parameters, partial correlation analysis and Pearson’s correlation analysis were conducted. Patients with SLE showed lower values for the ALPS index in the left (1.543 ± 0.141 vs 1.713 ± 0.175, P < 0.001), right (1.428 ± 0.142 vs 1.556 ± 0.139, P < 0.001) and whole (1.486 ± 0.121 vs 1.635 ± 0.139, P < 0.001) brain compared with the HC group. Reduced ALPS index showed significant positive correlations with grey matter loss. The non-invasive ALPS index could serve as a sensitive and effective neuroimaging biomarker for individually quantifying glymphatic activity in patients with SLE. Glymphatic system abnormality may be involved in the pathophysiologic mechanism underlying CNS damage in SLE patients.
21 May 2025 in Rheumatology
Objectives: Cognitive dysfunction is a common neuropsychiatric manifestation in SLE, particularly affecting processing speed (PS) and memory. This study aims to identify behaviourally relevant topological networks of functional connectivity underlying neuropsychological test performances, using connectome-based predictive modelling (CPM). Methods: Forty-three SLE patients and 34 controls underwent overall cognitive screening, with SLE patients additionally undergoing neurocognitive assessments for PS and memory. Resting-state fMRI was performed to construct functional connectivity matrices. CPM with leave-one-out cross-validation was employed to model the association between functional connectivity and cognitive performances. Linear regression and moderation analyses were employed to identify risk factors for cognitive dysfunction in SLE. Results: CPM models predicted PS and memory scores in SLE in cross-validation, with correlation coefficients (r) between predicted and observed scores ranging from 0.40 to 0.42 (all P < 0.01). Key brain regions contributing to these models commonly included the cingulate cortex, dorsolateral prefrontal cortex, hippocampus, thalamus and cerebellum, which were critical nodes of default mode, frontoparietal and subcortical networks. A combined CPM model incorporating these functional connectomes predicted overall cognitive ability in SLE (r = 0.38, P < 0.05), with no predictive power in controls, confirming specificity. Additionally, higher damage indices were associated with slower PS. Disease activity, daily glucocorticoids dosage and anticardiolipin antibodies levels moderated associations between functional connectivity strength and cognitive performances. Conclusion: CPM identified brain networks that underlie critical cognitive functions in individuals and these neural fingerprints could potentially assist the diagnosis of cognitive dysfunction in SLE.